The data displays the revenue and net income of biotechnology company Biogen Idec from 2007 to 2017. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer. In 2017, Biogen Idec generated revenues worth around 12.3 billion USD.
2007 | 3171.6 | 579.8 |
2008 | 4097.5 | 790.1 |
2009 | 4377.3 | 977.1 |
2010 | 4716.4 | 898.6 |
2011 | 5048.6 | 1266.7 |
2012 | 5516.5 | 1380 |
2013 | 6932.2 | 1862.3 |
2014 | 9703.3 | 2941.5 |
2015 | 10763.8 | 3593.2 |
2016 | 11448.8 | 3695.7 |
2017 | 12273.9 | 2670.1 |